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randomly assigned to a low-protein diet supplemented with a-keto acid
group(keto acid group,31 patients),low-protein diet group(LPD group,26
patients)and routine protein diet group(RPD group,21 patients)were
investigated and followed up for one year. The nutritional parameters were
measured, and examinations of residual renal function (RRF), Kt/v, clearance of
creatinine (Ccr) and levels of serum amino acids, mean arterial pressure (MAP),
peritoneal ultraﬁltration(UF),residual urine volume(RUV) and the status of
water-sodium retentio were performed. Compared to LPD group, serum levels
of prealbumin(PA), transferrin (TRF) retinal binding protein (RBP) had a
signiﬁcant increment both in keto acid group and RPD group(P/0.01),but there
was no signiﬁcance between these two groups(pS0.05)&Compared to RPD
group, There was an incremental tendency in albumin(Alb), total
cholesterol(TC), triglyceride (TG), Triceps skinfoles (TSF),midarm riuscle
circumference(MAMC),body mass index(BMI) in keto acid group, but no
signiﬁcance(pS0.05)&The serum concentrations of Valine(Val),Leucine(Leu),
Isoleucine (Ile) were signiﬁcantly increased in keto acid group(p/
0.01),compared to the other groups. Levels of RRF, Kt/V, Ccr, RUV were
signiﬁcantly higher both in keto acid group and LPD group than in RPD
group(p/0.01)&There were no signiﬁcant differences in MAP, UF and
peritoneal dialysate albumin loss between these groups, However, the trend of
peritoneal dialysate albumin loss in keto acid group and LPD group was
descendent& Proteinuria decreased most signiﬁcantly in keto acid group (P/
0.01).In conclusion, Low-protein diet supplemented with a-keto acids therapy
has a tendency of protecting RRF in CAPD patients while relieving
malnutritional status and improving the 1evels of branched chain amino acids.
http://dx.doi.org/10.1016/j.krcp.2012.04.590
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a-KETOACIDS ON HYPERTROPHY OF DIABETIC GLOMERULUS AND ITS
RELATIONSHIP WITH THE LEVEL OF CYCLIN KINASE INHIBITOR P27
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Low-protein diet supplemented with a-keto acids was reported to have
renoprotective roles in diabetic nephropathy via inhibiting glomerular
hypertrophy, however, the mechanism has not yet been fully clariﬁed. the
cyclin kinase inhibitor p27 play an important role in hypertrophy of diabetic
glomerulus, The objective of the present study was to investigate the
relationship between the cyclin kinase inhibitor p27 and the effect of low-
protein diet supplemented with a-keto acids on hypertrophy of diabetic
glomerulus in rats. STZ-induced diabetic rats were given low-protein diet(5&
protein in fodder, LPD group)or low-protein diet supplemented with a-keto
acids(5& protein in fodder including 1& protein supplied by a-keto acids,
LPDþa-KA group)or normal-protein diet(10&protein in fodder, NPD group)for
8 weeks&The p27 protein of glomerular lysate was detected with Western
Blot. The extracellular matrix (ECM)protein(type IV collagen and ﬁbronectin) of
glomerular lysate and 24 h urine albumin were examined with ELISA& Image
analysis system was used to detect the diameter of each glomerulus.
Glomerular p27 protein increased in diabetic rats no matter what kinds of diet
were given, meanwhile,the 24h urine albumin, glomerular ECM,glomerular
diameter elevated as well as the ratio of kidney weight over body weight in
diabetic rats&Both low-protein diet and low-protein diet supplemented with
a-keto acids could attenuate changes occurred in diabetic rats with normal-
protein diet&Glomerular p27 level(8.672.3 vs 11.173.6,P/0.01),24 h urine
albumin(13.2172.49)mg&24 h vs (18.1373.23)mg&24 h,P/0.01,glomerular
diameter(652773)mm2 vs (721775)mm2,P/0.05,and the ratio of kidney
weight over body weight(11.0271.72 vs 12.0371.85,P/0.05)were lower in
LPDþa-KA group than LPD group. Solely glomerular p27 level was linearly
related with the ratio of kidney weight over body weight in diabetic rats&The
blood glucose and serum albumin remained constant in diabetic rats no matter
what kinds of diet were given. In conclusion, Low-protein diet supplemented
with a-keto acids can further inhibit glomerular hypertrophy,and may protect
diabetic glomerulus through decrease of glomerular p27 level.
http://dx.doi.org/10.1016/j.krcp.2012.04.591
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CRP is a recognized marker of systemic inﬂammation. The degree to which
CRP is associated with carotid and/or femoral intima media thickness (IMT),
markers of atherosclerosis, may quantify the degree to which inﬂammation
explains cardiovascular disease in patients with end stage renal disease. The
purpose of this study was to estimate the association between CRP and both
carotid and femoral IMT in hemodialysis (HD) patients. The present cross-
sectional study is nested in the Sevelamer hydrochloride and ultrasound-
measured femoral and carotid intima media thickness progression in end
stage renal disease (SUMMER) clinical trial. Carotid (common, internal and
bifurcation) and femoral arteries were visualized in B-mode ultrasonography.
CRP was measured in serum. The study cohort included 177 HD patients
(39.5% female, mean age 67.8711.5 years). All measures of both carotid and
femoral IMT were signiﬁcantly, positively associated with CRP. Compared to
subjects without, subjects with PVD, coronary revascularization and
hypertension had signiﬁcantly higher CRP levels. Conversely, subjects treated
with sevelamer hydrochloride had signiﬁcantly lower CRP levels than those
not exposed to this medication. CRP was signiﬁcantly, positively associated
with serum phosphorus, calcium and PTH, and signiﬁcantly inversely
associated with HDL. In conclusion, CRP is signiﬁcantly, positively associated
with both femoral and carotid IMT and suggests an association between
inﬂammation and atherosclerosis in HD patients.
http://dx.doi.org/10.1016/j.krcp.2012.04.592
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WALKING PERFORMANCE IN HEMODIALYSIS PATIENTS
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Patients with advanced CKD have impaired walking function that
predisposes them to falls and disability. Deﬁcits in walking function are
traditionally ascribed to declines in physical function. However, walking
impairment in certain clinical populations may also result from a
phenomenon known as cognitive-motor interference. This is characterized
by reductions in motor task performance (e.g., walking speed) when
simultaneously performing a cognitive task, and is termed a dual task cost
(DTC). The purpose of this study was to compare the contribution of
cognitive interference to decrements in walking performance in
hemodialysis patients and healthy controls.
14 hemodialysis patients (10M,4F, age¼48.5þ/-11.8) and 14 age-matched
healthy controls (9M, 5F, age¼48.5þ/- 10.1) participated. Each completed a
walking task in a control and dual task condition. The walking task involved
walking at a comfortable pace 4 times across a 26’GAITRite TM mat. The ﬁrst
2 trials were completed with no cognitive task and the last 2 trials with a
simultaneous task that consisted of generating a modiﬁed word list. Walking
performance was quantiﬁed with normalized gait speed, step length, base of
support, and step time. DTC was determined for each variable as the %
difference in performance between the single task and dual task.
Major metrics of walking function under standard conditions were
impaired by 20-40% in hemodialysis patients vs controls (po0.05 for each.).
In addition, CKD patients had a greater DTC for velocity, cadence, step time
and double support, than the control group (po0.05), and trends for greater
DTC for step length and width (p ¼ 0.07).
These data indicate that walking impairments in hemodialysis patients are
not due exclusively to declines in physical function, but that cognitive-motor
interference also plays a signiﬁcant role. This has signiﬁcant clinical
importance, as therapies designed to improve walking performance and
physical function, such as nutritional and exercise interventions, may need to
be augmented with cognitive training in order to have maximum beneﬁts.
http://dx.doi.org/10.1016/j.krcp.2012.04.593
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The food industry over the last decade has undergone a major
transformation in the way they manufacture food, often to the detriment of
nutritional paradigms. Two key components are pivotal to many of these
changes: salt and phosphate food additives. Traditional databases of food
composition, especially for processed foods, are no longer relevant. Phosphorus
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